Offer - Urjas Oil for just ₹ 1 X
Stamlo Trio Tablet is an allopathic medicine The correct dosage of Stamlo Trio Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Stamlo Trio Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Stamlo Trio Tablet safe for pregnant women?
Stamlo Trio Tablet should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Stamlo Trio Tablet safe during breastfeeding?
Information about safety of Stamlo Trio Tablet for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Stamlo Trio Tablet on the Kidneys?
Kidney can be affected by Stamlo Trio Tablet. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Stamlo Trio Tablet on the Liver?
The liver can be affected by Stamlo Trio Tablet. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Stamlo Trio Tablet only after medical advice.
What is the effect of Stamlo Trio Tablet on the Heart?
Stamlo Trio Tablet is completely safe for the heart.
Stamlo Trio Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Stamlo Trio Tablet unless your doctor advises you to do so -
Is this Stamlo Trio Tablet habit forming or addictive?
Stamlo Trio Tablet does not cause addiction.
Interaction between Food and Stamlo Trio Tablet
There isn't any research available on the side effects of taking Stamlo Trio Tablet with food.
Interaction between Alcohol and Stamlo Trio Tablet
Side effects of drinking alcohol and taking Stamlo Trio Tablet at the same time are rare and minor. However, if you face any side effects, talk to your doctor immediately.
Stamlo Trio Tablet contains telmisartan which is an antihypertensive drug that works by preventing a chemical (angiotensin II) to bind with a receptor. This causes relaxation of blood vessels, it also prevents the synthesis and release of aldosterone (a hormone whose hyperactivity results in high blood pressure). In this way Stamlo Trio Tablet decreases the blood pressure.
No, Stamlo Trio Tablet doesn't cause a headache. However, if you experience a headache while using Stamlo Trio Tablet, please consult your doctor without any delay.
Yes, Stamlo Trio Tablet causes hyponatremia (low level of sodium in the blood). Treatment with telmisartan might call for a regular blood monitoring for checking sodium levels.
Stamlo Trio Tablet is available in the form of tablets. A tablet is usually taken once a day, with or without food because food affects the absorption of this drug. It should be taken at exactly the same time every time to avoid skipping the dose. Stamlo Trio Tablet might start showing the effects between 2 to 4 weeks, therefore, it is important to continue taking it even when you feel well. One should take Stamlo Trio Tablet exactly as prescribed by their doctor.
Stamlo Trio Tablet is the brand name for telmisartan. It belongs to a group of medications known as angiotensin II receptor blockers. It is available in the form of tablets. Stamlo Trio Tablet is used to treat hypertension. It is also used to decrease cardiovascular risk in patients who cannot take ACE (angiotensin-converting enzyme) inhibitors.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148